• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Turquoise Health Raises $20M for Healthcare Pricing Platform, Launches Direct Contracting Platform

by Fred Pennic 05/11/2022 Leave a Comment

What You Should Know:

– Turquoise Health, an end-to-end healthcare pricing platform, today announced a $20M Series A investment led by existing investor Andreessen Horowitz (a16z), with participation from Bessemer, Box Group, and new investor Tiger Global.

– Turquoise Health will use the funding to continue making transparent pricing ubiquitous for all healthcare stakeholders: payers, providers, and patients.

Direct Contracting Platform

Turquoise Health Raises $20M for Healthcare Pricing Platform, Launches Direct Contracting Platform

In anticipation of July payer rates disclosures, Turquoise Health has launched its direct contracting platform, Clear Contracts, a SaaS platform that streamlines the direct contracting process between providers and purchasers atop a foundation of pricing data. Turquoise Health is focused on creating a streamlined pre-revenue cycle powered by simplified contracts. Clear Contracts will support Single Case Agreements, Retrospective Out of Network Agreements, and Group Health agreements. Today providers and purchasers connect on the Turquoise Platform to negotiate, redline, and sign data-driven contracts.

The company already sees an impact on patient behavior. While most of Turquoise Health’s downstream pricing data reaches care navigation platforms through a Pricing API, thousands of patients browse the Turquoise Health website each month for affordable care across hospitals in all 50 states. The company seeks to spread clear pricing data to patient encounters at all sites of care.

“We’re committed to a vision of the new ‘pre-revenue cycle’ where patients and payers know the costs upfront and providers become accustomed to real-time payment for shoppable services,” said Turquoise Health Co-Founder and CEO Chris Severn. “By creating a clean, easy-to-use direct contracting platform, Turquoise Health is shifting the industry’s focus towards complete financial certainty prior to care ultimately resulting in less friction between patients, providers, and payers.”

Tagged With: Andreessen Horowitz, API, behavior, Box, Drug-Price Transparency, Healthcare Price Transparency, healthcare pricing, Payers, price transparency, revenue cycle

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |